Abstract
Purpose
The use of medicines among newborns admitted to intensive care units is characterized by a high prevalence of off-label/unlicensed use and a wide variability in the absence of international guidelines. A prospective cross-sectional study was organized with the aim to analyse drug prescriptions among all 107 Italian level III neonatal intensive care units.
Methods
An online questionnaire was used to collect detailed information for each newborn, and a classification was made about the license status of all prescriptions. In addition, prescriptions were analysed taking into account a practical guide prepared by the Italian Society of Neonatology (ISN).
Results
The 1-day survey (May–July 2014) regarded 220 newborn infants admitted to 36/107 Italian neonatal intensive care units: 191 prematures and 29 born at term. In total, 720 prescriptions (corresponding to 79 different drugs) were analysed: 191 (26.5 %) followed the terms of the product license, 529 (73.5 %) were off-label or unlicensed: 193/220 newborns (87.7 %) received at least one off-label/unlicensed prescription. Antiinfectives were the most common medicine used, followed by respiratory drugs and antianaemics; in an off-label manner, the most common was cardiovascular and central nervous system (CNS) drugs, gastrointestinals and antiinfectives. The most common categories of off-label use were age (34.4 %) and dosing frequency (20.6 %). Compared to ISN practical guide, prescriptions adhered more frequently to indications (100 % for ampicillin/sulbactam, >80 % for ampicillin, fluconazole, fentanyl, ranitidine and vancomicin).
Conclusions
Our results confirm the high prevalence of off-label/unlicensed drug use in the neonatal population and underline a better adherence to indications based on clinical practice, suggesting the need to update information contained in the data sheets of medicines.
Similar content being viewed by others
References
Cuzzolin L (2014) Variability in drug use among newborns admitted to NICUs: a proposal for a European multicentre study. J Pediatr Neonatal Individual Med 3(1), e030122. doi:10.7363/030122
Van Riet-Nales DA, de Jager KE, Schobben AF, Egberts TC, Rademaker CM (2011) The availability and age-appropriateness of medicines authorized for children in the Netherlands. Br J Clin Pharmacol 72:465–473. doi:10.1111/j.1365-2125.2011.03982.x
Mason J, Pirmohamed M, Nunn T (2012) Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature. Eur J Clin Pharmacol 68:21–28. doi:10.1007/s00228-011-1097-1
Conroy S (2011) Association between licence status and medication errors. Arch Dis Child 96:305–306. doi:10.1136/adc.2010.191940
Agostino R, Braguglia A, Caccamo ML, Dotta A, Massenzi L, Messner H, Sorrentino E (2009) Farmacoterapia neonatale: guida pratica (con software interattivo). Biomedia Ed, Milan
American Academy of Pediatrics (2014) Policy statement: off-label use of drugs in children. Pediatrics 133(3):563–567. doi:10.1542/peds.2013-4060
Olski TM, Lampus SF, Gherarducci G, Saint Raymond A (2011) Three years of paediatric regulation in the European Union. Eur J Clin Pharmacol 67:245–252. doi:10.1007/s00228-011-0997-4
EMA document (2013) Successes of the paediatric regulation after 5 years. EMA/250577/2013. Available at: http://www.ema.europa.eu/ema/index.jsp?curl-pages/news_and_events/news/2013/06/news_detail_001823.jsp&mid-WC0b01ac058004d5c1 Accessed 19 Aug 2013
Pansieri C, Bonati M, Choonara I, Jacqz-Aigrain E (2014) Neonatal drug trials: impact of EU and US paediatric regulations. Arch Dis Child Fetal Neonatal Ed (online first). doi:10.1136/archdischild-2013-305900
Cuzzolin L (2014) Off-label drug in the newborn. J Pediatr Neonat Individual Med 3(2), e030224. doi:10.7363/030224
Conroy S, McIntyre J, Choonara I (1999) Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonat Ed 80:F142–F145. doi:10.1136/fn.80.2.F142
Avenel S, Bomkratz A, Dassieu G, Janaud JC, Danan C (2000) The incidence of prescriptions without marketing product license in a neonatal intensive care unit. Arch Pediatr 7:143–147. doi:10.1016/S0929-693x(00)88083-5
T’ Jong GW, Vulto AG, De Hoog M, Schimmel JM, Tibboel D, Van den Anker JN (2001) A survey of the use of off-label and unlicensed drugs in a Dutch Children’s Hospital. Pediatrics 108:1089–1093. doi:10.1542/peds.108.5.1089
Lopez-Martinez R, Cabanas Poy MJ, Oliveras Arenas M, Clemente Bautista S (2005) Utilizacion de medicamentos en una UCI neonatal: studio prospectivo. Farm Hosp 29:26–29
Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, Tolsa J, Fanconi S, Pannatier A (2006) Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med Wkly 136:218–222
Prandstetter C, Tamesberger M, Wagner O, Weissensteiner M, Wiesinger-Eidenberger G, Weidinger I, Lechner E (2009) Medical prescriptions to premature and newborn infants in an Austrian neonatal intensive care unit. Klin Pediatr 221:312–317. doi:10.1055/s-0029-1220903
Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H (2009) Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther 34:277–287. doi:10.1111/j.1365-2710.2008.01005.x
Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W (2010) Drug utilization on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur J Clin Pharmacol 66:87–95. doi:10.1007/s00228-009-0722-8
Nguyen KA, Claris O, Kassai B (2011) Unlicensed and off-label drug use in a neonatal unit in France. Acta Paediatr 100:615–617. doi:10.1111/j.1651-2227.2010.02103.x
Lass J, Käär R, Jõgi K, Varendi H, Metsvaht T, Lutsar I (2011) Drug utilization pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol 67:1263–1271. doi:10.1007/s00228-011-1072-x
Kimland E, Nydert P, Odlind V, Böttiger Y, Lindemalm S (2012) Paediatric drug use with focus on off-label prescriptions at Swedish hospitals—a nationwide study. Acta Paediatr 101:772–778. doi:10.1111/j.1651-2227.2012.02656.x
Oguz SS, Kanmaz HG, Dilmen U (2012) Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study. Int J Clin Pharm 34:136–141. doi:10.1007/s11096-011-9604-0
Palčevski G, Skočibušić N, Vlahović-Palčevski V (2012) Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey. Eur J Clin Pharmacol 68:1073–1077. doi:10.1007/s00228-012-1221-x
Kieran EA, O’Callaghan N, O’Donnell CPF (2014) Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study. Acta Paediatr 103:e139–e142. doi:10.1111/apa.12541
Lindell-Osuagwu L, Hakkarainen M, Sepponen K, Vainio K, Naaranlahti T, Kokki H (2014) Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation. J Clin Pharm Ther 39:144–153. doi:10.1111/jcpt.12119
Dell’Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, Quaranta R, Dell’Erba AS (2007) Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci 29:361–367. doi:10.1007/s11096-006-9081-z
Dessì A, Salemi C, Fanos V, Cuzzolin L (2010) Drug treatments in a neonatal setting: focus on the off-label use in the first month of life. Pharm World Sci 32:120–124. doi:10.1007/s11096-009-9356-2
Laforgia N, Nuccio MM, Schettini F, Dell’Aera M, Gasbarro AR, Dell’Erba A, Solarino B (2014) Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy. Pediatr Int 56:57–59. doi:10.1111/ped.12190
Porta A, Esposito S, Menson E, Spyridis N, Tsolia M, Sharland M, Principi N (2010) Off-label antibiotic use in children in three European countries. Eur J Clin Pharmacol 66(9):919–927. doi:10.1007/s00228-010-0842-1
Manzoni P, Mostert M, Jacqz-Aigrain E, Farina D (2009) The use of fluconazole in neonatal intensive care units. Arch Dis Child 94:983–987. doi:10.1136/ adc.2008.154385
Benjamin DK, Hudak ML, Duara S et al (2014) Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial. JAMA 311(17):1742–1749. doi:10.1001/jama.2014.2624
Pansieri C, Pandolfini C, Jacqz-Aigrain E, van den Anker J, Bonati M (2015) Fluconazole prophylaxis in neonates. Arch Dis Child 100(1):75–76. doi:10.1136/ archdischild-2014-306771
Pappas PG, Kauffman CA, Andes D et al (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503–535. doi:10.1086/596757
Kaguelidou F, Pandolfini C, Manzoni P, Choonara I, Bonati M, Jacqz-Aigrain E (2012) European survey on the use of prophylactic fluconazole in neonatal intensive care units. Eur J Pediatr 171:439–445. doi:10.1007/s00431-011-1565-8
Pandolfini C, Sequi M, Manzoni P, Bonati M (2013) The use of ciprofloxacin and fluconazole in Italian neonatal intensive care units: a nationwide survey. BMC Pediatr 13:5. doi:10.1186/1471-2431-13-5
Malcom WF, Cotton CM (2012) Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates. Clin Perinatol 39(1):99–109. doi:10.1016/j.clp.2011.12.015
Laughon MM, Avant D, Tripathi N, Hornik CP, Cohen-Wolkowiez M, Clark RH, Smth PB, Rodriguez W (2014) Drug labelling and exposure in neonates. JAMA Pediatr 168(2):130–136. doi:10.1001/jamapediatrics.2013.4208
Terrin G, Passariello A, De Curtis M, Manguso F, Salvia G, Lega L, Messina F, Paludetto R, Berni Canani R (2012) Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics 129:e40–e45. doi:10.1542/peds.2011-0796
Tighe M, Afzal NA, Bevan A, Hayen A, Munro A, Beattie RM (2014) Pharmacological treatment of children with gastro-oesophageal reflux. Cochrane Database Syst Rev 11, CD008550. doi:10.1002/14651858.CD008550.pub2
Haiden N, Klebermass K, Cardona F, Schwindt J, Berger A, Kohlhauser-Vollmuth C, Jilma B, Pollak A (2006) A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. Pediatrics 118:180–188. doi:10.1542/peds.2005-2475
Acknowledgments
Special thanks to all neonatologists who collaborated to the collection of the data (in alphabetical order): Domenico Antonio Agostino (AO San Giovanni Addolorata, Roma), Antonietta Auriemma (AO Bolognini, Seriate, Bergamo), Adriano Azzali (Ospedale San Giovanni di Dio, Agrigento), Manuela Bedetta (Policlinico Casilino, Roma), Tatiana Boetti (Ospedale Sant’Anna, Torino), Lina Bollani (Policlinico San Matteo, Pavia), Raffaele Borrelli (AOU Parma), Angela Bossi (Ospedale Del Ponte, Varese), Roberto Bottino (Fondazione Poliambulanza, Brescia), Matteo Bruschettini (Istituto Gaslini, Genova), Elsa Buffone (AO San Camillo-Forlanini, Roma), Anna Casani (AO Rummo, Benevento), Alessandra Casati (Ospedale Belcolle, Viterbo), Giacomo Cavallaro (Fondazione IRCCS Ca’ Granda Ospedale Maggiore, Milano), Roksana Chakrokh (Ospedale Maggiore, Bologna), Natalia Chukhlantseva (Ospedale Bambin Gesù, Roma), Elena Ciarmoli (Fondazione Monza e Brianza, Monza), Gloria Cristofori (Fondazione IRCCS Ca’ Granda Ospedale Maggiore, Milano), Angelica Dessì (AOU Cagliari), Beatrice Gambi (Ospedale San Giovanni di Dio, Firenze), Giancarlo Gargano (Arcispedale Santa Maria Nuova, Reggio Emilia), Valeria Ghiglione (Ospedale Spalto, Marengo, Alessandria), Paolo Ghirri (AOU Pisana, Pisa), Nicola Laforgia (AOU Policlinico, Bari), Stefania Liguori (Ospedale Maria Vittoria, Torino), Valeria Anna Manfredini (Ospedale di Rho, Milano), Luca Massenzi (Fatebenefratelli-Isola Tiberina, Roma), Anna Claudia Massolo (Ospedale Bambin Gesù, Roma), Federico Matina (Spedali Civili, Brescia), Fabio Natale (Azienda Policlinico Umberto I, Roma), Emilia Parodi (AO Ordine Mauriziano, Torino), Luisa Pieragostini (Ospedale San Filippo Neri, Roma), Matteo Rinaldi (Ospedali Riuniti di Foggia), Daniele Roncati (AOU Careggi, Firenze), Cristina Ruspaggiati (AOU Parma), Vincenzo Salvo (AOU Policlinico G. Martino, Messina), Maria Cristina Siviero (Ospedale Sant’Eugenio, Roma), Elena Sorrentino (Fatebenefratelli-Ospedale San Pietro, Roma) and Paolo Tagliabue (Ospedale San Gerardo, Monza).
Some data of this study have been presented as a poster at the 11th International Workshop on Neonatology on October 2015, Cagliari (Italy).
Contributions of author statement
Rocco Agostino and Laura Cuzzolin defined the study and the online questionnaire. Laura Cuzzolin performed the analysis of the data and wrote the first draft of the manuscript. Rocco Agostino critically reviewed the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cuzzolin, L., Agostino, R. Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study. Eur J Clin Pharmacol 72, 117–123 (2016). https://doi.org/10.1007/s00228-015-1962-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-015-1962-4